Collaboration and Partnerships in Accelerating Cancer Drug Development
Lorna Rothery spoke to the Cancer Drug Development Forum’s Managing Director, Professor Jaap Verweij and Chairperson of the CDDF Board of Directors, Professor Ruth Plummer, about opportunities and challenges in oncology research and treatment.
Liver inflammation’s role in cancer treatment resistance
Is the a link between liver inflammation and cancer treatment outcomes? Researchers have found why certain cancers become resistant to immunotherapy.
Advocating for equity in childhood cancer care
A scarcity of suitable therapies and geographic disparities in access to care are impacting survival rates for children with cancer; Lorna Rothery spoke to the European branch of Childhood Cancer International, a pan-European organisation committed to improving outcomes for children and adolescents affected by cancer.
Microwave ablation emerges as a promising treatment for thyroid cancer
Researchers suggest that microwave ablation, a minimally invasive procedure, could offer comparable progression-free survival rates to surgery with fewer complications.
Breakthrough prostate cancer treatment shows less side affects and better outcomes
A minimally invasive treatment for prostate cancer, using a combination of MRI and transurethral ultrasound, has shown effectiveness in a recent study.
Endocrine disrupting chemicals: the role they play in breast cancer
Dr Alice Di Pasquale, Scientific Research Officer at Breast Cancer UK, explains why more must be done to increase awareness of Endocrine Disrupting Chemicals and breast cancer risk.
Scientists record a decline in cancer related deaths among rising cancer cases
New research looks at cancer cases in the UK, revealing complex factors driving progress and challenges.
Drug development could help treat one of the most challenging cancers
A new drug development could help those battling pancreatic cancer, one of the most challenging cancers to treat.
Predicting improved response to lung cancer immunotherapy
Researchers have identified 140 genes that could change how non-small cell lung cancer (NSCLC) patients are treated with immunotherapy and low-dose radiation.
World Cancer Day: Digital cancer care to address UK inequity
Paul Landau, CEO of Careology, a digital cancer care platform used by the NHS and private health sector, posits the need for smart investment into digital tools to support cancer care and maximise the efficiency of resources.
AI cancer treatment: AI tool to enhance precision for cancer treatment
A new cutting-edge artificial intelligence tool has been developed to revolutionise cancer treatment.
People-centred health services are essential to reducing disparities in cancer care
The past ten years have seen significant progress in cancer care, detecting cancers earlier and managing them more successfully and less invasively on a global scale.
Skin cancer mutation offers hope for healing broken hearts
Is there a way to mend a broken heart? Biomedical engineers have found a potential way to mend a broken heart using a genetic mutation commonly associated with skin cancers.
The non-invasive cancer-grade probing system
Researchers have introduced a non-invasive method for determining the malignancy grade of glioma tumours.
AI unlocks cancer treatment secrets
Using artificial intelligence, scientists have tackled one of the toughest challenges in cancer research.
Researchers reveal blood cell traits influence risk of rare blood cancer
Scientists have revealed how common variations in our blood cells can act as unexpected allies to cancer-causing mutations.
Unraveling the potential of antisense therapies to target neuropilin 1 in the fight against...
Secarna Pharmaceuticals, the next-generation antisense drug discovery and development company, is developing novel approaches to successfully target Neuropilin 1 (NRP1), a promising target for the treatment of cancer.
Secarna aims to expand the therapeutic toolbox against cancer
Current oncology treatments have significantly improved cancer survival rates, but more effective and safer therapeutics are needed.
Personalised treatment shows promising results in leukaemia trial
A new personalised treatment has been discovered for the most common form of adult leukaemia, which has been found to help patients live longer.
Daily exercise linked to prolonged life in inoperable lung cancer
A life-extending link has been discovered between minimum physical activity and inoperable lung cancer.